Literature DB >> 31746031

microRNA-501-5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1.

Xiang Ma1, Jiaxi Feng1, Ming Lu1, Wenjuan Tang2, Jianbo Han3, XiaGang Luo1, Qinghong Zhao1, Li Yang4.   

Abstract

In spite of the achievement in treatment, the gastric cancer (GC) mortality still remains high. MicroRNAs (miRNAs) are a group of small noncoding RNAs that play a crucial part in tumor progression. In this study, we explored the expression and function of microRNA-501-5p (miR-501-5p) in GC cell lines. Quantitative real-time polymerase chain reaction assay results suggested that miR-501-5p was significantly upregulated in GC tissues and cell lines. And, the Cell Counting Kit-8 colony formation and cell migration assay results showed that the downregulation of miR-501-5p decreased GC cell proliferation and migration. Besides that, we found that GC cell cycle was arrested in G2 phase and cell apoptosis rate was increased by silencing the expression of miR-501-5p in GC cell lines using the flow cytometry. We also found that miR-501-5p could directly target lysophosphatidic acid receptor 1 (LPAR1) and negatively regulate LPAR1 expression in GC cell lines by performing dual-luciferase reporter gene assay and Western blot analysis. And, LPAR1 was significantly downregulated in GC tissues and inversely correlated with miR-501-5p expression. Furthermore, LPAR1 downregulation promoted cell proliferation and migration, which were attenuated by cotransfection of miR-501-5p inhibitor in GC cells. In conclusion, miR-501-5p can promote GC cell proliferation and migration by targeting and downregulating LPAR1. miR-501-5p/LPAR1 may become a potential therapeutic target for GC treatment.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  LPAR1; gastric cancer; miR-501-5p; migration; proliferation

Mesh:

Substances:

Year:  2019        PMID: 31746031     DOI: 10.1002/jcb.29426

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma.

Authors:  Andrea Martins-da-Silva; Mirella Baroni; Karina Bezerra Salomão; Pablo Ferreira das Chagas; Ricardo Bonfim-Silva; Lenisa Geron; Gustavo Alencastro Veiga Cruzeiro; Wilson Araújo da Silva; Carolina Alves Pereira Corrêa; Carlos Gilberto Carlotti; Rosane Gomes de Paula Queiroz; Suely Kazue Nagahashi Marie; Silvia Regina Brandalise; José Andrés Yunes; Carlos Alberto Scrideli; Elvis Terci Valera; Luiz Gonzaga Tone
Journal:  Cell Mol Neurobiol       Date:  2022-04-02       Impact factor: 5.046

Review 2.  Lysophosphatidic Acid Signaling and microRNAs: New Roles in Various Cancers.

Authors:  Mahdi Rafiyan; Mohammad Hassan Jafari Najaf Abadi; Seyed Saeed Tamehri Zadeh; Michael R Hamblin; Mahboubeh Mousavi; Hamed Mirzaei
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

3.  Regenerative Effects of Hypoxia Primed Flowable Placental Formulation in Muscle and Dermal Injury.

Authors:  Sandeep Dhall; Min Sung Park; Chaoyang Li; Malathi Sathyamoorthy
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

4.  miR‑224‑5p regulates the proliferation, migration and invasion of pancreatic mucinous cystadenocarcinoma by targeting PTEN.

Authors:  Xiaobo Peng; Chengtao Guo; Yanjun Wu; Mingzhen Ying; Renxu Chang; Lele Song; Lixing Zhan; Xianbao Zhan
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

5.  Plasma Small Extracellular Vesicle-Carried miRNA-501-5p Promotes Vascular Smooth Muscle Cell Phenotypic Modulation-Mediated In-Stent Restenosis.

Authors:  Xiao-Fei Gao; Zhi-Mei Wang; Ai-Qun Chen; Feng Wang; Shuai Luo; Yue Gu; Xiang-Quan Kong; Guang-Feng Zuo; Xiao-Min Jiang; Guan-Wen Ding; Yan Chen; Zhen Ge; Jun-Jie Zhang; Shao-Liang Chen
Journal:  Oxid Med Cell Longev       Date:  2021-04-21       Impact factor: 6.543

6.  Upregulation of miR-1269 Contributes to the Progression of Esophageal Squamous Cell Cancer Cells and Is Associated With Poor Prognosis.

Authors:  Xiuhui Bai; Qiang Wang; Xueqi Rui; Xiaohua Li; Xianming Wang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec

7.  M2 macrophages-derived exosomal microRNA-501-3p promotes the progression of lung cancer via targeting WD repeat domain 82.

Authors:  Jie Lei; Peng Chen; Feng Zhang; Na Zhang; Jianfei Zhu; Xiaoping Wang; Tao Jiang
Journal:  Cancer Cell Int       Date:  2021-02-05       Impact factor: 5.722

8.  MicroRNA-Related Prognosis Biomarkers from High-Throughput Sequencing Data of Colorectal Cancer.

Authors:  Xiao-Liang Xing; Zhi-Yong Yao; Ti Zhang; Ning Zhu; Yuan-Wu Liu; Jing Peng
Journal:  Biomed Res Int       Date:  2020-09-09       Impact factor: 3.411

9.  Up-regulation of microRNA miR-101-3p enhances sensitivity to cisplatin via regulation of small interfering RNA (siRNA) Anti-human AGT4D and autophagy in non-small-cell lung carcinoma (NSCLC).

Authors:  Dong Cui; Yu Feng; Rulin Qian
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

10.  Long non-coding RNA TRPM2-AS regulates microRNA miR-138-5p and PLAU (Plasminogen Activator, Urokinase) to promote the progression of gastric adenocarcinoma.

Authors:  Jun Sun; Fang Zhou; Juan Xue; Chunyan Ji; Yinzong Qu; Yuwei Pan
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.